Principal Financial Group Inc. Raises Position in GE HealthCare Technologies Inc. $GEHC

Principal Financial Group Inc. grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 554,183 shares of the company’s stock after purchasing an additional 11,484 shares during the quarter. Principal Financial Group Inc.’s holdings in GE HealthCare Technologies were worth $45,454,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in GEHC. Vanguard Group Inc. raised its position in shares of GE HealthCare Technologies by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after buying an additional 267,058 shares during the period. Dodge & Cox raised its position in shares of GE HealthCare Technologies by 16.8% in the 3rd quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock worth $2,066,550,000 after buying an additional 3,949,361 shares during the period. Capital Research Global Investors raised its position in shares of GE HealthCare Technologies by 25.0% in the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after buying an additional 4,998,154 shares during the period. Hotchkis & Wiley Capital Management LLC raised its position in shares of GE HealthCare Technologies by 17.1% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock worth $633,271,000 after buying an additional 1,232,828 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in shares of GE HealthCare Technologies by 8.9% in the 3rd quarter. Dimensional Fund Advisors LP now owns 5,362,717 shares of the company’s stock worth $402,647,000 after buying an additional 438,439 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 3.5%

NASDAQ:GEHC opened at $63.47 on Friday. The business’s 50-day moving average is $71.92 and its two-hundred day moving average is $77.34. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The firm has a market capitalization of $28.87 billion, a PE ratio of 15.18, a price-to-earnings-growth ratio of 1.38 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts predict that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.35%.

Insider Buying and Selling

In other news, insider Frank R. Jimenez purchased 1,750 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The stock was acquired at an average cost of $60.45 per share, for a total transaction of $105,787.50. Following the completion of the purchase, the insider owned 93,932 shares of the company’s stock, valued at approximately $5,678,189.40. This trade represents a 1.90% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Peter J. Arduini purchased 4,169 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average price of $59.92 per share, with a total value of $249,806.48. Following the completion of the purchase, the chief executive officer directly owned 259,424 shares of the company’s stock, valued at approximately $15,544,686.08. This represents a 1.63% increase in their position. The SEC filing for this purchase provides additional information. Over the last three months, insiders bought 9,229 shares of company stock worth $556,180. Corporate insiders own 0.36% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on GEHC shares. Citigroup cut their target price on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research report on Thursday, April 30th. Piper Sandler cut their target price on GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. BNP Paribas Exane cut their price objective on GE HealthCare Technologies from $95.00 to $88.00 in a research report on Friday, May 1st. BTIG Research cut their price objective on GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Finally, Oppenheimer reissued an “outperform” rating and issued a $85.00 price objective on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Eight analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $80.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.